Clinical trial for Prostate Carcinoma
Official title Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
ClinicalTrials.gov ID: NCT07377006
What this study is testing
- What it's testing
- The study aims to find out what helps patients complete genetic testing and how well a new decision support tool works.
- Who it's for
- This study is looking for patients with prostate cancer.
- What's involved
- Participants will use a decision support tool to help them decide whether to get genetic testing.
- Time commitment
- The source text does not specify the duration or number of visits.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Diagnosed prostate cancer patients receiving care at Lyndon B. Johnson (LBJ) Hospital
- Were recommended for germline genetic testing by their oncology provider
- Can provide informed consent
- Can communicate in English or Spanish
You likely can't join if
- Prostate cancer patients receiving care at LBJ who are unable to participate due to a serious psychological or cognitive condition
The study team makes the final eligibility decision.
Where it is enrolling
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Houston, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.